Zimmer Biomet Holdings (ZBH) Accumulated Expenses (2010 - 2026)

Zimmer Biomet Holdings has reported Accumulated Expenses for 17 years, with the latest figure at $334.3 million in Q2 2026.

• On a quarterly basis, Accumulated Expenses changed N/A year-over-year to $334.3 million in Q2 2026; TTM through Jun 2026 was $334.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $477.1 million, down 32.47% from the prior year.
• Accumulated Expenses was $334.3 million for Q2 2026 at Zimmer Biomet Holdings, up from $293.9 million in the prior quarter.
• The five-year high for Accumulated Expenses was $803.6 million in Q4 2023, with the low at $184.5 million in Q1 2022.
• Average Accumulated Expenses over 5 years is $427.7 million, with a median of $334.3 million recorded in 2026.
• The sharpest annual moves came in 2023 and 2025: Accumulated Expenses soared 38.0% in 2023, then tumbled 32.47% in 2025.
• Over 5 years, Accumulated Expenses stood at $582.3 million in 2022, then jumped by 38.0% to $803.6 million in 2023, then slipped by 12.08% to $706.5 million in 2024, then sank by 32.47% to $477.1 million in 2025, then decreased by 29.93% to $334.3 million in 2026.
• The last three Accumulated Expenses figures came in at $334.3 million (Q2 2026), $293.9 million (Q1 2026), and $477.1 million (Q4 2025), per Business Quant data.